The reported cash and cash equivalents provide a snapshot of the company's liquidity at the end of FY23. While the figure is a crucial indicator of financial health, without comparative figures from previous periods or additional context regarding the company's burn rate or future funding needs, it's challenging to assess the impact on the stock price directly. Therefore, the score is neutral, but the relevance and importance are high due to the direct financial nature of the information.